Evidence map›Paper›PMID 15642144›Full record

ArticleArthritis research & therapy2005

Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction.

Martin Skoumal, Günther Haberhauer, Gernot Kolarz, Gerhard Hawa, Wolfgang Woloszczuk, Anton Klingler

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Arthritis research & therapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 87 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Exploring the role of cathepsin in rheumatoid arthritis.Saudi journal of biological sciences · 2022
    Review
  9. Review
  10. Article
  11. Article
  12. Cathepsin K: The Action in and Beyond Bone.Frontiers in cell and developmental biology · 2020
    Review
  13. Article
  14. Review
  15. Lysosomes as a therapeutic target.Nature reviews. Drug discovery · 2019
    Review
  16. Article
  17. Review
  18. Article
  19. The Utility of Biomarkers in Osteoporosis Management.Molecular diagnosis & therapy · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Martin SkoumalInstitut für Rheumatologie der Kurstadt Baden in Kooperation mit der Donauuniversität Krems, Austria. martin.skoumal@a1.net
Günther Haberhauer
Gernot Kolarz
Gerhard Hawa
Wolfgang Woloszczuk
Anton Klingler
Donauspital · ATLudwig Boltzmann Institute for Experimental and Clinical Traumatology · ATUniversity Hospital Innsbruck · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cathepsin K is a cysteine protease that plays an essential role in osteoclast function and in the degradation of protein components of the bone matrix by cleaving proteins such as collagen type I, collagen type II and osteonectin. Cathepsin K therefore plays a role in bone remodelling and resorption in diseases such as osteoporosis, osteolytic bone metastasis and rheumatoid arthritis. We examined cathepsin K in the serum of 100 patients with active longstanding rheumatoid arthritis. We found increased levels of cathepsin K compared with a healthy control group and found a significant correlation with radiological destruction, measured by the Larsen score. Inhibition of cathepsin K may therefore be a new target for preventing bone erosion and joint destruction in rheumatoid arthritis. However, further studies have to be performed to prove that cathepsin K is a valuable parameter for bone metabolism in patients with early rheumatoid arthritis.

Indexed as

Bone RemodelingAdolescentAdultAgedAge FactorsAntibodies, AntinuclearAntirheumatic AgentsArthritis, RheumatoidAutoimmune DiseasesBiomarkersBlood SedimentationBone and BonesBone ResorptionCathepsin KCathepsinsC-Reactive ProteinAntibodies, AntinuclearAntirheumatic AgentsBiomarkersCathepsin KCathepsinsC-Reactive ProteinCTSK protein, humanHemoglobins

Identifiers

PMID15642144
PMCPMC1064888
OpenAlexW2136276667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.